Learn More
Invitrogen™ CD45 Monoclonal Antibody (HI30), Pacific Blue™

Description
The Mouse anti-Human CD45 Monoclonal Antibody (mAb) recognizes the CD45 antigen1, which is expressed on all cells of hematopoietic origin with the exception of platelets and red blood cells and their immediate precursors. CD45 is considered to be a pan leukocyte marker. For this Pacific Blue™ conjugate - Excitation/Peak Emission (nm): 405/455.
Specifications
Specifications
| Antigen | CD45 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | HI30 |
| Concentration | 0.2 mg/mL |
| Conjugate | Pacific Blue |
| Formulation | PBS with 4mg/mL BSA and 0.1% sodium azide |
| Gene | PTPRC |
| Gene Accession No. | P08575 |
| Gene Alias | B220; cd45; CD45 antigen; CD45 antigen isoform 1 precursor; CD45 antigen isoform 2 precursor; CD45 antigen isoform 3 precursor; CD45 antigen isoform 4 precursor; CD45 antigen isoform 5 precursor; CD45 antigen isoform 6 precursor; CD45R; GP180; Lca; L-CA; leucocyte common antigen; leukocyte common antigen; leukocyte common antigen A; leukocyte common antigen B; leukocyte common antigen, CD45; loc; LOW QUALITY PROTEIN: receptor-type tyrosine-protein phosphatase C; LY5; Ly-5; lymphocyte antigen 5; lymphocyte common antigen; Lyt-4; membrane tyrosine phosphatase; protein tyrosine phosphatase lambda; protein tyrosine phosphatase receptor type C; protein tyrosine phosphatase, receptor type C; protein tyrosine phosphatase, receptor type, C; protein tyrosine phosphatase, receptor type, c polypeptide; Protein tyrosine phosphatase, receptor-type, c polypeptide; protein tyrosine phosphatase; alternatively spliced; Ptprc; Receptor-type tyrosine-protein phosphatase C; RT7; T200; T200 glycoprotein; T200 leukocyte common antigen; T220 and B220 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.